About Tirzepatide
            
            Class: | GLP-1 receptor agonist  
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.  
Adult dose: | Initial dose is 5 mg subcutaneously once weekly; may be increased to 10 mg after 4 weeks based on individual response and tolerability.  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in individuals under 18 years of age.  
Side effects: | Common side ef
         
        
            
                
                
                    
                        Drug Class
                    
                    GLP-1 receptor agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator (2°C to 8°C/36°F to 46°F); may be kept at room temperature (up to 30°C/86°F) for up to 21 days after first use. Do not freeze.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Eli Lilly & Co Inc., U.S.A
                    
                    
                    Package Size
                    4 Prefilled Pens
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1734.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose is 5 mg subcutaneously once weekly; may be increased to 10 mg after 4 weeks based on individual response and tolerability.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in individuals under 18 years of age.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite, and injection site reactions.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and in patients with a known hypersensitivity to tirzepatide or any component of the formulation.
         
        
        
            
                Important Warnings
            
            Risk of thyroid C-cell tumors; pancreatitis; renal impairment; hypoglycemia when used with other antidiabetic agents; and gastrointestinal adverse reactions. Monitor for signs of pancreatitis and discontinue if suspected.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.